NutriBand Inc. (NTRB) stock
NTRBNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends January 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 4, 2026Score 4/30183% above fair value
$4.82−0.77 (-13.77%)
Close on Nov 18, 2026Market cap $58.59MP/E –Yield –
NutriBand operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
NutriBand's operating income for the twelve months ending Jul 31, 2026 was -$7.05M. For fiscal 2026 it was -$8.32M. The highest annual figure on record is -$151.26K in fiscal 2017.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | -$8.32M | – |
| FY2025 | Jan 31, 2025 | -$10.28M | – |
| FY2024 | Jan 31, 2024 | -$4.87M | – |
| FY2023 | Jan 31, 2023 | -$4.48M | – |
| FY2022 | Jan 31, 2022 | -$6.11M | – |
| FY2021 | Jan 31, 2021 | -$2.60M | – |
| FY2020 | Jan 31, 2020 | -$1.97M | – |
| FY2019 | Jan 31, 2019 | -$3.33M | – |
| FY2018 | Jan 31, 2018 | -$2.67M | – |
| FY2017 | Jan 31, 2017 | -$151.26K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | -$890.64K | – |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | -$1.25M | – |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | -$1.02M | – |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | -$3.88M | – |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | -$2.00M | – |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | -$1.41M | – |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | -$5.56M | – |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | -$1.43M | – |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | -$1.41M | – |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | -$1.89M | – |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | -$1.31M | – |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | -$1.72M | – |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | -$824.19K | – |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | -$1.02M | – |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | -$1.68M | – |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | -$1.07M | – |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | -$1.03M | – |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | -$685.88K | – |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | -$3.78M | – |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | -$314.06K | – |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | -$2.18M | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | -$40.95K | – |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | -$225.82K | – |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | -$147.49K | – |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | -$616.09K | – |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | -$330.57K | – |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | -$449.61K | – |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | -$573.16K | – |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | -$515.75K | – |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | -$488.62K | – |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | -$1.88M | – |
| Q1 FY2019CQ1 2018 | Apr 30, 2018 | -$448.10K | – |
| Q4 FY2018CQ4 2017 | Jan 31, 2018 | -$2.44M | – |
| Q3 FY2018CQ3 2017 | Oct 31, 2017 | -$107.73K | – |
| Q2 FY2018CQ2 2017 | Jul 31, 2017 | -$92.96K | – |
| Q1 FY2018CQ1 2017 | Apr 30, 2017 | -$35.62K | – |
| Q4 FY2017CQ4 2016 | Jan 31, 2017 | -$33.58K | – |
| Q3 FY2017CQ3 2016 | Oct 31, 2016 | -$29.98K | – |
| Q2 FY2017CQ2 2016 | Jul 31, 2016 | -$35.62K | – |
See a number that looks wrong?